End-of-day quote
Taiwan S.E.
23:00:00 08/05/2024 BST
|
5-day change
|
1st Jan Change
|
50.9
TWD
|
-0.39%
|
|
+0.20%
|
-8.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,066
|
6,041
|
15,759
|
17,519
|
6,158
|
5,925
|
Enterprise Value (EV)
1 |
4,270
|
4,948
|
12,727
|
12,522
|
3,877
|
4,890
|
P/E ratio
|
12
x
|
11.6
x
|
8.87
x
|
5.06
x
|
35.2
x
|
-54.7
x
|
Yield
|
7.42%
|
7.73%
|
6.73%
|
9.09%
|
2.59%
|
-
|
Capitalization / Revenue
|
1.37
x
|
1.85
x
|
2.99
x
|
2.15
x
|
3.62
x
|
6.62
x
|
EV / Revenue
|
1.16
x
|
1.51
x
|
2.42
x
|
1.53
x
|
2.28
x
|
5.47
x
|
EV / EBITDA
|
6.94
x
|
6.7
x
|
5.44
x
|
2.78
x
|
11.4
x
|
-64.2
x
|
EV / FCF
|
117
x
|
8.24
x
|
6.75
x
|
5.54
x
|
-7.77
x
|
-17.8
x
|
FCF Yield
|
0.86%
|
12.1%
|
14.8%
|
18%
|
-12.9%
|
-5.61%
|
Price to Book
|
1.54
x
|
1.7
x
|
3.25
x
|
2.38
x
|
1.03
x
|
1.01
x
|
Nbr of stocks (in thousands)
|
104,668
|
104,883
|
106,124
|
106,174
|
106,174
|
106,174
|
Reference price
2 |
48.40
|
57.60
|
148.5
|
165.0
|
58.00
|
55.80
|
Announcement Date
|
12/03/19
|
17/03/20
|
11/03/21
|
25/02/22
|
22/02/23
|
01/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,691
|
3,271
|
5,268
|
8,162
|
1,703
|
894.3
|
EBITDA
1 |
614.9
|
738
|
2,342
|
4,510
|
340.3
|
-76.13
|
EBIT
1 |
495.6
|
624.8
|
2,202
|
4,366
|
198.7
|
-216.3
|
Operating Margin
|
13.43%
|
19.1%
|
41.79%
|
53.5%
|
11.67%
|
-24.18%
|
Earnings before Tax (EBT)
1 |
528.4
|
648
|
2,206
|
4,359
|
289.7
|
-135.5
|
Net income
1 |
427
|
525.4
|
1,778
|
3,476
|
175
|
-107.9
|
Net margin
|
11.57%
|
16.06%
|
33.75%
|
42.59%
|
10.28%
|
-12.06%
|
EPS
2 |
4.040
|
4.960
|
16.74
|
32.60
|
1.648
|
-1.020
|
Free Cash Flow
1 |
36.56
|
600.8
|
1,885
|
2,259
|
-498.7
|
-274.2
|
FCF margin
|
0.99%
|
18.37%
|
35.78%
|
27.68%
|
-29.29%
|
-30.66%
|
FCF Conversion (EBITDA)
|
5.94%
|
81.4%
|
80.5%
|
50.1%
|
-
|
-
|
FCF Conversion (Net income)
|
8.56%
|
114.35%
|
106.03%
|
65%
|
-
|
-
|
Dividend per Share
2 |
3.590
|
4.450
|
10.00
|
15.00
|
1.500
|
-
|
Announcement Date
|
12/03/19
|
17/03/20
|
11/03/21
|
25/02/22
|
22/02/23
|
01/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
795
|
1,093
|
3,032
|
4,997
|
2,281
|
1,035
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
36.6
|
601
|
1,885
|
2,259
|
-499
|
-274
|
ROE (net income / shareholders' equity)
|
13.3%
|
15.4%
|
42.3%
|
57%
|
2.63%
|
-1.83%
|
ROA (Net income/ Total Assets)
|
8.54%
|
9.96%
|
27.3%
|
37.1%
|
1.63%
|
-2.13%
|
Assets
1 |
4,998
|
5,277
|
6,515
|
9,361
|
10,718
|
5,073
|
Book Value Per Share
2 |
31.40
|
33.90
|
45.60
|
69.30
|
56.10
|
55.20
|
Cash Flow per Share
2 |
1.260
|
1.930
|
5.810
|
2.180
|
2.770
|
0.4900
|
Capex
1 |
295
|
208
|
295
|
781
|
138
|
103
|
Capex / Sales
|
8%
|
6.37%
|
5.6%
|
9.57%
|
8.1%
|
11.53%
|
Announcement Date
|
12/03/19
|
17/03/20
|
11/03/21
|
25/02/22
|
22/02/23
|
01/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -8.78% | 167M | | +17.76% | 66.7B | | +0.84% | 48.83B | | +17.11% | 41.51B | | +18.68% | 26.72B | | +11.45% | 19.58B | | +3.89% | 18.01B | | -21.31% | 16.02B | | +3.82% | 15.58B | | -7.57% | 15.7B |
Other Specialty Chemicals
|